| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |